Evidence map›Paper›PMID 17997524›Full record

ArticleAnalytical chemistry2007

Screening for ligands of human retinoid X receptor-alpha using ultrafiltration mass spectrometry.

Dongting Liu, Jian Guo, Yan Luo, David J Broderick, Michael I Schimerlik, John M Pezzuto, Richard B van Breemen

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Recent developments in protein-ligand affinity mass spectrometry.Analytical and bioanalytical chemistry · 2011
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Dongting LiuDepartment of Medicinal Chemistry and Pharmacognosy, University of Illinois College of Pharmacy, 833 South Wood Street, Chicago, Illinois 60612, USA.
Jian Guo
Yan Luo
David J Broderick
Michael I Schimerlik
John M Pezzuto
Richard B van Breemen
University of Illinois Chicago · USOregon State University · USIllinois College · USUniversity of Hawaii at Hilo · US

Funding

Structural BiologyP01CA048112 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PEZZUTO, JOHN M. · 1991 to 2009
$12.4M
NCI NIH HHS 5 P01 CA48112NCI NIH HHS P01 CA048112
6 · The paper itself

Abstract

Retinoid X receptors (RXRs) function as ligand-activated transcription factors and are obligatory components of a large number of nuclear receptor heterodimers. RXRs help regulate diverse physiological responses including the cancer prevention responses of cell proliferation, inflammation, cell differentiation, and apoptosis. Since RXRs represent important targets for cancer chemoprevention, an ultrafiltration mass spectrometry-based assay was developed to facilitate the discovery of potential chemoprevention agents that bind to human RXRalpha. Natural and synthetic ligands for RXRalpha including 9-cis-retinoic acid, docosahexaenoic acid, and LG100268 could be detected and identified in DMSO (dimethyl sulfoxide) or even complex matrixes such as extracts of marine bacteria. Specific binding of ligands to RXRalpha was demonstrated through competitive binding using ultrafiltration LC-MS/MS (liquid chromatography-tandem mass spectrometry), and ligands could be ranked in order of affinity for RXRalpha. Therefore, ultrafiltration LC-MS/MS is suitable for the screening of complex mixtures such as natural product extracts for the discovery of new ligands to RXRalpha.

Indexed as

ChemopreventionChromatography, LiquidDrug Evaluation, PreclinicalHumansLigandsMass SpectrometryRetinoid X ReceptorsUltrafiltrationLigandsRetinoid X Receptors

Identifiers

PMID17997524
PMCPMC2570161
OpenAlexW2019765911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.